awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34439528-D78625C2-59D7-4F9E-AFF7-3E553C9D5D2D
Q34439528-D78625C2-59D7-4F9E-AFF7-3E553C9D5D2D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34439528-D78625C2-59D7-4F9E-AFF7-3E553C9D5D2D
Randomized efficacy and safety trial of once-daily remogliflozin etabonate for the treatment of type 2 diabetes.
P2860
Q34439528-D78625C2-59D7-4F9E-AFF7-3E553C9D5D2D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34439528-D78625C2-59D7-4F9E-AFF7-3E553C9D5D2D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6f851a98eef0b2ce8edda02a68ed3856fd19148a
P2860
Remogliflozin etabonate, a selective inhibitor of the sodium-dependent transporter 2 reduces serum glucose in type 2 diabetes mellitus patients.